David E. Wheadon, M.D.

Former Senior Vice President, AstraZeneca Plc
Dr. Wheadon has served on our board of directors since May 2022. Dr. Wheadon served as Senior Vice President of Global Regulatory Affairs, Patient Safety, and Quality Assurance at AstraZeneca Plc from December 2014 to July 2019. Prior to that, he was Executive Vice President, Research and Advocacy at Juvenile Diabetes Research Foundation International Inc., from May 2013 to December 2014, and Senior Vice President, Scientific and Regulatory Affairs at Pharmaceutical Research and Manufacturers of America (PhRMA), from January 2009 to May 2013. Dr. Wheadon served as Vice President, Global Pharmaceutical Regulatory and Medical Science, and Group Vice President, Global Pharmaceutical Regulatory Affairs at Abbott Laboratories from 2005 to 2009. Prior to Abbott Laboratories, Dr. Wheadon held senior regulatory and clinical development leadership positions at GlaxoSmithKline Plc and Eli Lilly and Company. Dr. Wheadon holds a M.D. from Johns Hopkins University School of Medicine and an A.B. in Biology from Harvard University. He completed his post-doctoral psychiatry fellowship at the Boston VA Medical Center and Tufts New England Medical Center. Dr. Wheadon also serves on the boards of Karuna Therapeutics Inc., Sotera Health Company, and Vaxart, Inc.